Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

ACUTE CONFUSIONAL STATES AND DEPRESSION TREATED WITH MAPROTILINE MESYLATE - REPORT OF 4 PATIENTS SUCCESSFULLY TREATED IN AN INTENSIVE-CARE UNIT SOUTH AFRICAN MEDICAL JOURNAL BROCKUTNE, J. G., GOODWIN, N. M., Hicks, J. C. 1979; 55 (16): 641-642

Abstract

Four patients admitted to hospital with multiple injuries developed psychiatric symptoms after an initially favourable response to intensive therapy. Alterations in the level of consciousness and behavioural pattern were observed, associated with the presence of acute depression, possibly endogenous in origin. Within 24--48 hours of intravenous administration of maprotiline mesylate (Ludiomil, Ciba), a tetracyclic antidepressant drug, considerable improvement was noted in all 4 patients, with regard to both the depressive state and the clouding of consciousness. The importance of recognizing psychiatric disorders in severely ill patients in an intensive therapy environment is stressed.

View details for Web of Science ID A1979GR80900018

View details for PubMedID 462281